‌

US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease

Patent 11759506 was granted and assigned to Voyager Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Voyager Therapeutics

Current Assignee

Voyager Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Maria Scheel

Bernard Ravina

Date of Patent

September 19, 2023

Patent Application Number

16523567

Date Filed

July 26, 2019

Patent Citations

US Patent 7125706 Method for the production and purification of adenoviral vectors

US Patent 7169612 Use of EDG2 receptor in an animal model of heart failure

US Patent 7182944 Methods of increasing distribution of nucleic acids

US Patent 7186552 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same

US Patent 7198951 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor

US Patent 7223585 Viral purification methods

US Patent 7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues

US Patent 7238526 Methods and cell line useful for production of recombinant adeno-associated viruses

...

Patent Primary Examiner

Patent abstract

The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.